Viagra + Khaleesi = Vyleesi?

A second drug designed to enhance women’s libido, Vyleesi, has been approved by the FDA, rekindling a debate around what role pharmaceuticals should play in human sexuality. Vyleesi, or bremelanotide, is the second drug for hypoactive sexual disorder. The first, Addyi, was approved in 2005, and came with a black-box safety warning that prohibited women from drinking alcohol before taking it. That stymied sales of the drug — and analysts don’t think Vyleesi, made by AMAG Pharmaceuticals, will likely do much better.

Though the new drug doesn’t have the same safety concerns, it has to be injected — and only offers marginal improvements in libido.